# A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects

> **NCT07099118** · PHASE1 · RECRUITING · sponsor: **Sunshine Lake Pharma Co., Ltd.** · enrollment: 96 (estimated)

## Conditions studied

- Non - Alcoholic Steatohepatitis

## Interventions

- **DRUG:** HEC169584 capsule
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT07099118
- **Lead sponsor:** Sunshine Lake Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-03
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-03-06
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07099118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07099118, "A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07099118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*